Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cancer science [Cancer Sci] NLMUID: 101168776"" wg kryterium: JN


Tytuł :
ACTN4 gene amplification is a predictive biomarker for adjuvant chemotherapy with UFT in stage I lung adenocarcinomas.
Autorzy :
Noro R; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Honda K; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, Japan.; Department of Bioregulation, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Nagashima K; Research Center for Medical and Health Data Science, Keio University Hospital, Tokyo, Japan.
Motoi N; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.; Department of Pathology, Saitama Cancer Center, Saitama, Japan.
Kunugi S; Department of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Matsubayashi J; Department of Anatomical Pathology, Tokyo Medical University, Tokyo, Japan.
Takeuchi S; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.; Department of Surgery, Tokyo Medical University, Tokyo, Japan.
Shiraishi H; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, Japan.
Okano T; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.; Department of Surgery, Tokyo Medical University, Tokyo, Japan.
Kashiro A; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, Japan.; Department of Bioregulation, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Meng X; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, Japan.; Department of Bioregulation, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Yoshida Y; Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
Watanabe S; Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
Usuda J; Department of Thoracic Surgery, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Inoue T; Department of Thoracic Surgery, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Wilber H; Abnova, 9th Floor, No. 108, Jhouzih Street, Neihu District, Taipei City, 114, Taiwan.
Ikeda N; Department of Surgery, Tokyo Medical University, Tokyo, Japan.
Seike M; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Gemma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Kubota K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 29. Date of Electronic Publication: 2021 Nov 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
Autorzy :
Luo R; Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China.
Zheng C; Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China.
Song W; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China.
Tan Q; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China.
Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China.
Han X; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 29. Date of Electronic Publication: 2021 Nov 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
SUMOylation regulates Rb hyperphosphorylation and inactivation in uveal melanoma.
Autorzy :
Meng F; Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai, 200031, China.; Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.; NHC Key Laboratory of Myopia, Fudan University, Shanghai, China.
Yuan Y; Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai, 200031, China.; Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.; NHC Key Laboratory of Myopia, Fudan University, Shanghai, China.
Ren H; Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai, 200031, China.; Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.; NHC Key Laboratory of Myopia, Fudan University, Shanghai, China.
Yue H; Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai, 200031, China.; Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.; NHC Key Laboratory of Myopia, Fudan University, Shanghai, China.
Xu B; Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai, 200031, China.; Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.; NHC Key Laboratory of Myopia, Fudan University, Shanghai, China.
Qian J; Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai, 200031, China.; Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.; NHC Key Laboratory of Myopia, Fudan University, Shanghai, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 28. Date of Electronic Publication: 2021 Nov 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The E239K mutation abolishes the suppressive effects of LSD1 on the migration and invasion of MCF7 cells.
Autorzy :
Zhang Y; China-Japan Union Hospital, Jilin University, Changchun Jilin, China.; College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Wu T; China-Japan Union Hospital, Jilin University, Changchun Jilin, China.
Zhao B; China-Japan Union Hospital, Jilin University, Changchun Jilin, China.; School of Life Sciences, Jilin University, Changchun Jilin, China.
Liu Z; China-Japan Union Hospital, Jilin University, Changchun Jilin, China.; School of Life Sciences, Jilin University, Changchun Jilin, China.
Qian R; China-Japan Union Hospital, Jilin University, Changchun Jilin, China.
Zhang J; China-Japan Union Hospital, Jilin University, Changchun Jilin, China.; School of Life Sciences, Jilin University, Changchun Jilin, China.
Shi Y; China-Japan Union Hospital, Jilin University, Changchun Jilin, China.
Wan Y; China-Japan Union Hospital, Jilin University, Changchun Jilin, China.
Zhe L; Division of Genetics, Brigham and Women's Hospital and Department of Medicine, Harvard Medical School, Boston, USA.
Hu X; China-Japan Union Hospital, Jilin University, Changchun Jilin, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 27. Date of Electronic Publication: 2021 Nov 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma.
Autorzy :
Nakano T; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Neurosurgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.; Department of Brain Disease Translational Research, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Fujimoto K; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Neurosurgery, Graduate School of Life Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto, Japan.
Tomiyama A; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Brain Disease Translational Research, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.; Department of Neurosurgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Takahashi M; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Achiha T; Department of Neurosurgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Arita H; Department of Neurosurgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Kawauchi D; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Neurological Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8677, Japan.
Yasukawa M; Division of Cancer Stem Cell, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Masutomi K; Division of Cancer Stem Cell, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Kondo A; Department of Neurosurgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Narita Y; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Maehara T; Department of Neurosurgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Ichimura K; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Brain Disease Translational Research, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 27. Date of Electronic Publication: 2021 Nov 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy.
Autorzy :
Miyo M; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Kato T; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Nakamura Y; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Taniguchi H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Takahashi Y; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Ishii M; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan.
Okita K; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan.
Ando K; Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Yukami H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Mishima S; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Kotaka M; Gastrointestinal cancer center, Sano Hospital, Kobe, Japan.
Watanabe J; Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
Oba K; Interfaculty Initiative in Information Studies, The University of Tokyo, Tokyo, Japan.
Aleshin A; Natera, Inc, San Carlos, CA, USA.
Billings PR; Natera, Inc, San Carlos, CA, USA.
Rabinowitz M; Natera, Inc, San Carlos, CA, USA.
Kotani D; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Oki E; Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Takemasa I; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan.
Mori M; Tokai University School of Medicine, Isehara, Japan.
Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 27. Date of Electronic Publication: 2021 Nov 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma.
Autorzy :
Gao S; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Key Laboratory of Minimally Invasive Therapy Research for Lung Cancer, Chinese Academy of Medical Sciences.
Guo W; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Key Laboratory of Minimally Invasive Therapy Research for Lung Cancer, Chinese Academy of Medical Sciences.
Liu T; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liang N; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Ma Q; Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China.
Gao Y; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Tan F; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Key Laboratory of Minimally Invasive Therapy Research for Lung Cancer, Chinese Academy of Medical Sciences.
Xue Q; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Key Laboratory of Minimally Invasive Therapy Research for Lung Cancer, Chinese Academy of Medical Sciences.
He J; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 27. Date of Electronic Publication: 2021 Nov 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
Autorzy :
Rai S; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Inoue H; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Sakai K; Department of Genome Biology, Kindai University, Faculty of Medicine, Osakasayama, Japan.
Hanamoto H; Department of Hematology, Nara Hospital Kindai University, Faculty of Medicine, Ikoma, Japan.
Matsuda M; Department of Hematology, PL General Hospital, Tondabayashi, Japan.
Maeda Y; Department of Hematology, Minami Sakai Hospital, Sakai, Japan.
Haeno T; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Watatani Y; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Kumode T; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Serizawa K; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Taniguchi Y; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Hirase C; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Espinoza JL; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Morita Y; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Tanaka H; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Ashida T; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Tatsumi Y; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Nishio K; Department of Genome Biology, Kindai University, Faculty of Medicine, Osakasayama, Japan.
Matsumura I; Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 27. Date of Electronic Publication: 2021 Nov 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Mechanism of sensitivity to TPF chemoagents and its potential alternative of erbB2 in oral cancer with GDF15 overexpression.
Autorzy :
Zhao T; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
Zhou Z; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
Ju W; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
Liang S; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
Tang X; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
Zhu D; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
Zhang Z; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
Zhong L; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 26. Date of Electronic Publication: 2021 Nov 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Low Carbohydrate Diet and Risk of Cancer Incidence: the Japan Public Health Center-based Prospective Study.
Autorzy :
Cai H; Department of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, Suita Osaka, 565-0871, Japan.
Sobue T; Department of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, Suita Osaka, 565-0871, Japan.
Kitamura T; Department of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, Suita Osaka, 565-0871, Japan.
Ishihara J; Department of Food and Life Science, Azabu University, Sagamihara Kanagawa, 252-5201, Japan.
Nanri A; Department of Food and Health Sciences, International College of Arts and Sciences, Fukuoka Women's University, Fukuoka, 813-8529, Japan.; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku Tokyo, 162-8655, Japan.
Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku Tokyo, 162-8655, Japan.
Iwasaki M; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Chuo-ku Tokyo, 104-0045, Japan.
Yamaji T; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Chuo-ku Tokyo, 104-0045, Japan.
Inoue M; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Chuo-ku Tokyo, 104-0045, Japan.
Tsugane S; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Chuo-ku Tokyo, 104-0045, Japan.; National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, 162-8636, Japan.
Sawada N; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Chuo-ku Tokyo, 104-0045, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 25. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and autoantibody-antigen system.
Autorzy :
Wu J; College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China.; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.
Wang P; College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China.; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.
Han Z; College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China.; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.
Li T; College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China.; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.
Yi C; College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China.; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.
Qiu C; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou, 450052, China.
Yang Q; College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China.; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.
Sun G; College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China.; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.
Dai L; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou, 450052, China.
Shi J; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou, 450052, China.
Wang K; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.; Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou, 450052, China.
Ye H; College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China.; Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province 450052, PR China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 25. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cost-Effectiveness of Carbon-Ion Radiotherapy versus Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer.
Autorzy :
Okazaki S; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, 371-8511, Japan.; Gunma University Heavy Ion Medical Center, Maebashi, Gunma, 371-8511, Japan.
Shibuya K; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, 371-8511, Japan.
Takura T; Department of Healthcare Economics and Health Policy, University of Tokyo, Tokyo, 113-8655, Japan.
Miyasaka Y; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, 371-8511, Japan.
Kawamura H; Gunma University Heavy Ion Medical Center, Maebashi, Gunma, 371-8511, Japan.
Ohno T; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, 371-8511, Japan.; Gunma University Heavy Ion Medical Center, Maebashi, Gunma, 371-8511, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 25. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
METTL14 suppresses growth and metastasis of renal cell carcinoma by decreasing long non-coding RNA NEAT1.
Autorzy :
Liu T; Department of Urology, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.; Department of Urology, Changzheng Hospital, Naval Medical University, 415 Fengyang Road, Shanghai, 200003, China.
Wang H; Department of Urology, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.; Department of Emergency, Affiliated Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
Fu Z; Department of Urology, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Wang Z; Department of Urology, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Wang J; Department of Urology, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Gan X; Department of Urology, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Wang A; Department of Urology, Changzheng Hospital, Naval Medical University, 415 Fengyang Road, Shanghai, 200003, China.
Wang L; Department of Urology, Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai, 200433, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 23. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
PDRG1 promotes the proliferation and migration of GBM cells by MEK/ERK/CD44 pathway.
Autorzy :
Sun J; Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Laboratory of Clinical and Experimental Pathology, Department of Pathology, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Xu Y; Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.; Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Liu J; Department of Pathology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Cui H; Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Cao H; Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Ren J; Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 23. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis.
Autorzy :
Song X; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
An Y; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Chen D; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Zhang W; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Wu X; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Li C; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Wang S; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Dong W; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Wang B; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Liu T; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Zhong W; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Sun T; State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, 300350, China.
Cao H; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, 300052, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 23. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Aberrant RNA Splicing and Therapeutic Opportunities in Cancers.
Autorzy :
Yamauchi H; Cancer RNA Research Unit, National Cancer Center Research Institute, Japan.
Nishimura K; Cancer RNA Research Unit, National Cancer Center Research Institute, Japan.
Yoshimi A; Cancer RNA Research Unit, National Cancer Center Research Institute, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 23. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Recurrent PTPRZ1-MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases.
Autorzy :
Chai RC; Department of Molecular Neuropathology, Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Liu X; Department of Molecular Neuropathology, Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Pang B; Department of Molecular Neuropathology, Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Liu YQ; Department of Molecular Neuropathology, Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Li JJ; Department of Molecular Neuropathology, Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Li YF; Department of Molecular Neuropathology, Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Zhao Z; Department of Molecular Neuropathology, Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Du J; Department of Molecular Neuropathology, Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Bao ZS; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jiang T; Department of Molecular Neuropathology, Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 23. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms.
Autorzy :
Takei H; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, E/CLS-407, Boston, MA, 02215, USA.; Department of Hematology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi-shi, Maebashi, 371-8511, Japan.
Luiz Coelho-Silva J; Department of Medical Images, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo Ribeirão Preto, São Paulo, 14049-900, Brazil.
Tavares Leal C; Department of Medical Images, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo Ribeirão Preto, São Paulo, 14049-900, Brazil.
Queiroz Arantes Rocha A; Special Health Sciences Academic Unit, Federal University of Jataí, Jataí, 75801-615, Brazil.
Mantello Bianco T; Department of Medical Images, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo Ribeirão Preto, São Paulo, 14049-900, Brazil.
Welner RS; Department of Medicine, Division Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Mishima Y; Department of Clinical Medicine, Faculty of Medicine, Transborder Medical Research Center, University of Tsukuba, Tsukuba, 305-8577, Japan.
Kobayashi IS; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, E/CLS-407, Boston, MA, 02215, USA.
Mullally A; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
Lima K; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, 05508-900, Brazil.
Agostinho Machado-Neto J; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, 05508-900, Brazil.
Kobayashi SS; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, E/CLS-407, Boston, MA, 02215, USA.; Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, 277-8575, Japan.; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, 02215, USA.
Lobo de Figueiredo-Pontes L; Department of Medical Images, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo Ribeirão Preto, São Paulo, 14049-900, Brazil.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 22. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prognostic Impact of Schlafen 11 in Bladder Cancer Patients Treated with Platinum-based Chemotherapy.
Autorzy :
Taniyama D; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Sakamoto N; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Takashima T; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Department of Pathology, Graduate School of Medicine, Osaka University, Suita, Japan.
Takeda M; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pham QT; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Ukai S; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Maruyama R; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Harada K; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Babasaki T; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Department of Urology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
Sekino Y; Department of Urology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
Hayashi T; Department of Urology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
Sentani K; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pommier Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Murai J; Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.
Yasui W; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 22. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Glycosylation of MUC6 by α1,4-linked N-acetylglucosamine enhances suppression of pancreatic cancer malignancy.
Autorzy :
Yuki A; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.
Fujii C; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.; Department of Biotechnology, Interdisciplinary Cluster for Cutting Edge Research, Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan.
Yamanoi K; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
Matoba H; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.
Harumiya S; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.
Kawakubo M; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.
Nakayama J; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Nov 22. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies